Back to RHHBYView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Leukoencephalopathy, Progressive Multifocal
View Full LandscapeDrug Information
Target Indication
Leukoencephalopathy, Progressive Multifocal
Clinical Trial
NCT00120367Last updated: 9/1/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
emtricitabine/tenofovirPhase 3
HIV Infections
LHRH AgonistPhase 3
Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Trastuzumab in combination with pertuzumabPhase 3
Haematological Malignancy
Pegylated Interferon/ribavirinPhase 3
Chronic Hepatitis C
Peginterferon alpha-2a (Pegasys®)Phase 3
HIV Infections
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts